Chemotherapy for colorectal cancer
Chemotherapy uses anticancer (cytotoxic) drugs to destroy cancer cells. It is sometimes used to treat colorectal cancer. Your healthcare team will consider your personal needs to plan the drugs, doses and schedules of chemotherapy. You may also receive other treatments.
Chemotherapy is often combined with radiation therapy to treat rectal cancer. This is called chemoradiation. The 2 treatments are given during the same time period.
Chemotherapy is given for different reasons. You may have chemotherapy or chemoradiation to:
- destroy cancer cells in the body
- shrink a tumour before other treatments such as surgery (called neoadjuvant chemotherapy)
- destroy cancer cells left behind after surgery and reduce the risk that the cancer will come back (recur) (called adjuvant chemotherapy)
- relieve pain or control the symptoms of advanced colorectal cancer (called palliative chemotherapy)
Chemotherapy is usually a systemic therapy. This means that the drugs travel through the bloodstream to reach and destroy cancer cells all over the body, including those that may have broken away from the primary tumour in the colon or rectum. Chemotherapy may also be a regional therapy, which means that it is given to a specific area of the body.
Chemotherapy drugs used for colorectal cancer @(Model.HeadingTag)>
The most common chemotherapy drugs used to treat colorectal cancer are:
- 5-fluorouracil (Adrucil, 5-FU)
- capecitabine (Xeloda)
- oxaliplatin (Eloxatin)
- irinotecan (Camptosar)
- raltitrexed (Tomudex)
- trifluridine and tipiracil (Lonsurf)
Leucovorin (folinic acid) is a common drug used in treating colorectal cancer. It is not a chemotherapy drug but it helps 5-fluorouracil work better.
The most common chemotherapy drug combinations used to treat colorectal cancer are:
- 5-fluorouracil with leucovorin
- FOLFOX – leucovorin, 5-fluorouracil and oxaliplatin
- CAPOX (also called XELOX) – capecitabine and oxaliplatin
- FOLFIRI – leucovorin, 5-fluorouracil and irinotecan
- FOLFOXIRI – leucovorin, 5-fluorouracil, oxaliplatin, irinotecan
- CAPIRI – capecitabine and irinotecan
If colorectal cancer does not respond to drugs used in earlier treatments or if it comes back, the following drugs may be used:
- trifluridine and tipiracil
If colorectal cancer doesn’t respond to these drugs or if it recurs, you may be offered targeted therapy. A targeted therapy drug may be given along with chemotherapy.
For chemoradiation, the chemotherapy drugs that are usually given are 5-fluorouracil or capecitabine.
Hepatic arterial infusion may be used to treat liver metastases when cancer has only spread to the liver and it can’t be removed with surgery. It delivers chemotherapy directly to liver tumours through the main artery of the liver (called the hepatic artery). Floxuridine (FUDR) is the most common chemotherapy drug used for hepatic arterial infusion.
Side effects @(Model.HeadingTag)>
Side effects can happen with any type of treatment for colorectal cancer, but everyone’s experience is different. Some people have many side effects. Other people have only a few side effects.
Chemotherapy may cause side effects because it can damage healthy cells as it kills cancer cells. If you develop side effects, they can happen any time during, immediately after or a few days or weeks after chemotherapy. Sometimes late side effects develop months or years after chemotherapy. Most side effects go away on their own or can be treated, but some side effects may last a long time or become permanent.
Side effects of chemotherapy will depend mainly on the type of drug, the dose, how it’s given, the effects of other treatments and your overall health. Side effects of chemoradiation can be more severe than those of chemotherapy alone.
Some common side effects of chemotherapy drugs used for colorectal cancer are:
- low blood cell counts
- sore mouth and throat
- nausea and vomiting
- loss of appetite
- hair loss
- skin problems
- nervous system problems
Tell your healthcare team if you have these side effects or others you think might be from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.
American Cancer Society. Colorectal Cancer. 2018: https://www.cancer.org/cancer/colon-rectal-cancer.html.
American Society of Clinical Oncology. Colorectal Cancer. 2017: https://www.cancer.net/cancer-types/colorectal-cancer/view-all.
Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario;
Libutti SK, Saltz LB, Willett CG, Levine RA . Cancer of the colon. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 57: 768 - 812.
Libutti SK, Willett CG, Saltz LB, Levine RA . Cancer of the rectum. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 60: 823 - 841.
National Cancer Institute. Colon Cancer Treatment (PDQ®) Health Professional Version. 2018: https://www.cancer.gov/types/colorectal/hp/colon-treatment-pdq#section/all.
National Cancer Institute. Rectal Cancer Treatment (PDQ®) Health Professional Version. 2018: https://www.cancer.gov/types/colorectal/hp/rectal-treatment-pdq#section/all.
Wilkes GM . Colon, rectal, and anal cancers. Yarbro CH, Wujcki D, Holmes Gobel B, (eds.). Cancer Nursing: Principles and Practice. 8th ed. Burlington, MA: Jones and Bartlett Learning; 2018: 51: 1423 - 1485.